FACEECHO / Diagnostic labs
How should a diagnostic lab evaluate the business value and clinical limitations of a new patient-engagement service?
A lab should define the patient problem, test a specific workflow and measure usefulness against its operating cost. Evaluate clinical limitations separately from commercial interest. More tests ordered is not, by itself, proof that a service benefits patients.
Define a small, reviewable pilot
Specify who is invited, what they are asked to do and who handles questions. Record completion, staff time, technical problems and whether patients find the information useful. These are proposed evaluation measures, not published FaceEcho results.
Keep clinical decisions separate
An engagement tool should not be presented as deciding which tests someone needs. A facial scan is not a laboratory result. The clinician determines whether testing is appropriate; the lab should avoid using observations as an automatic sales trigger.
Compare benefit with effort
Before starting, agree what would justify continuing: clearer patient questions, acceptable staff workload or fewer workflow problems. Record total cost and unresolved concerns. Do not promise revenue, clinical benefit or return on investment without supporting results.
What is available from FaceEcho?
Guided scans, relevant questions, visible-observation reports, PDF download and user-controlled sharing are available. Lab booking, test routing and direct lab integration are not a standard live workflow. Discuss any proposed integration separately before representing it as available.
Key takeaways
- Define a patient need and a limited workflow before starting.
- Measure usefulness, staff effort and operating cost.
- Keep testing decisions with clinicians.
- Confirm integration scope separately from PDF downloads.